Erectile Dysfunction (Post-Cancer Treatment) Secondary to Prostate Cancer (Treated with Surgery, Radiation, or ADT)
Erectile Dysfunction (Post-Cancer Treatment) can develop as a service-connected secondary condition to Prostate Cancer (Treated with Surgery, Radiation, or ADT) when a medical nexus links the two under 38 CFR § 3.310. The strength of medical evidence for this specific pairing is strong. Erectile dysfunction is among the most common and severe quality-of-life consequences of prostate cancer treatment, affecting 60–90% of men treated with radical prostatectomy and 25–60% treated with radiation therapy.
How is Erectile Dysfunction (Post-Cancer Treatment) connected to Prostate Cancer (Treated with Surgery, Radiation, or ADT)?
Erectile dysfunction is among the most common and severe quality-of-life consequences of prostate cancer treatment, affecting 60–90% of men treated with radical prostatectomy and 25–60% treated with radiation therapy. Radical prostatectomy — even nerve-sparing — damages the cavernous nerves (branches of the pelvic splanchnic nerves) that course along the posterolateral prostate and mediate reflexogenic erection. Radiation therapy causes progressive obliterative endarteritis of the cavernous arteries and radiation fibrosis of the corpus cavernosum and penile neurovascular bundle. Androgen deprivation therapy (ADT) suppresses testosterone to castrate levels, abolishing both libido and erectile function via hypothalamic-pituitary-gonadal axis suppression. ED following prostate cancer treatment is expected, universal, and a medically established direct complication requiring no nexus letter in many cases.
“Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected.”
What evidence supports claiming Erectile Dysfunction (Post-Cancer Treatment) as secondary to Prostate Cancer (Treated with Surgery, Radiation, or ADT)?
Sanda MG et al. (2008) N Engl J Med (prostate cancer treatment outcomes); Resnick MJ et al. (2013) N Engl J Med (RP vs radiation ED long-term); Capogrosso P et al. (2019) Eur Urol (ED after prostate cancer treatment); Kim ED et al. (2001) Urology (nerve-sparing RP and ED).
How do I file a secondary claim for Erectile Dysfunction (Post-Cancer Treatment)?
This is one of the strongest and most straightforward secondary cancer-treatment claims. Prostate cancer treatment records (operative report for RP, radiation treatment plan/dosimetry records, ADT prescription records) directly establish the treatment nexus. Urology records documenting post-treatment ED evaluation and treatment. Consider for SMC-K separately. A nexus letter is generally easy to obtain and may not even be required given the well-established causal relationship documented in medical literature and treatment informed-consent documents.
How does the VA rate Erectile Dysfunction (Post-Cancer Treatment)?
Erectile Dysfunction (Post-Cancer Treatment) is rated under 38 CFR Part 4 using the diagnostic code assigned to that condition. The VA evaluates the severity of the secondary condition independently and assigns a rating from 0% to 100% in increments defined in the rating schedule. That rating is then combined with Prostate Cancer (Treated with Surgery, Radiation, or ADT) and all other service-connected conditions using the combined ratings formula under § 4.25.
Erectile Dysfunction (Post-Cancer Treatment) is rated under DC 7522 in 38 CFR Part 4.
Common Questions — Erectile Dysfunction (Post-Cancer Treatment) Secondary to Prostate Cancer (Treated with Surgery, Radiation, or ADT)
Can Erectile Dysfunction (Post-Cancer Treatment) be claimed as secondary to Prostate Cancer (Treated with Surgery, Radiation, or ADT)?
Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Erectile Dysfunction (Post-Cancer Treatment) is a documented secondary pairing for Prostate Cancer (Treated with Surgery, Radiation, or ADT) with strong medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.
What evidence proves Erectile Dysfunction (Post-Cancer Treatment) is caused by Prostate Cancer (Treated with Surgery, Radiation, or ADT)?
The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.
Does the VA combine or separately rate Erectile Dysfunction (Post-Cancer Treatment)?
The VA rates Erectile Dysfunction (Post-Cancer Treatment) separately under its own 38 CFR Part 4 diagnostic code, then combines it with Prostate Cancer (Treated with Surgery, Radiation, or ADT) and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.
What legal standard applies to secondary service connection?
38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.
How strong is the medical evidence for this pairing?
The medical evidence supporting Erectile Dysfunction (Post-Cancer Treatment) as secondary to Prostate Cancer (Treated with Surgery, Radiation, or ADT) is rated strong. Erectile dysfunction is among the most common and severe quality-of-life consequences of prostate cancer treatment, affecting 60–90% of men treated with radical prostatectomy and 25–60% treated with radiation therapy. Radical prostatectomy — even nerve-sparing — damages the cavernous nerves (branches of the pelvic splanchnic nerves) that course along the posterolateral prostate and mediate reflexogenic erection. Radiation therapy causes progressive obliterative endarteritis of the cavernous arteries and radiation fibrosis of the corpus cavernosum and penile neurovascular bundle. Androgen deprivation therapy (ADT) suppresses testosterone to castrate levels, abolishing both libido and erectile function via hypothalamic-pituitary-gonadal axis suppression. ED following prostate cancer treatment is expected, universal, and a medically established direct complication requiring no nexus letter in many cases.
Do I need a nexus letter for a secondary claim?
The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.
Get a Full Secondary Condition Analysis
VeteranHQ cross-references your complete medical history against the full secondary condition database, surfacing every secondary claim opportunity for your specific service-connected conditions.
Start Your Free Analysis